D,L-cis-2,3-Pyrrolidine dicarboxylate alters [3H]-L-glutamate binding and induces convulsions in mice

Pharmacology Biochemistry and Behavior

Volumn 76, Issue 2, 2003, Pages 295-299

  Sinhorin, Valéria Dornelles Gindri ^a   Carpes, Marcos José Souza ^b   Roehrs, Cheila ^a   Zimmer, Melissa Freire ^a   Sauzem, Patricia Dutra ^a   Rubin, Maribel Antonello ^a   Correia, Carlos Roque Duarte ^b   Mello, Carlos Fernando ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Binding; Convulsion; DNQX; Glutamate; Intracerebroventricular administration; MK 801

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; DEXTRO LEVO 2,3 PYRROLIDINE DICARBOXYLATE; DICARBOXYLIC ACID DERIVATIVE; DIZOCILPINE; GLUTAMIC ACID; GLUTAMIC ACID DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SODIUM; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CELL MEMBRANE; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; LATENT PERIOD; MALE; MEMBRANE BINDING; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0142258056     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.08.012     Document Type: Article

References (34)

1. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
2. Bridges R.J., Stanley M.S., Anderson M.W., Cotman C.W., Chamberlin A.R. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diasteroisomer. J. Med. Chem. 34:1991;717-725.
3. Carpes M.J.S., Miranda P.C.M.L., Correia C.R.D. Stereoselective synthesis of conformationally restricted analogues of aspartic and glutamic acids from endocyclic enecarbamates. Tetrahedron Lett. 38:1997;1869-1872.
4. Chamberlin A.R., Bridges R.J. Conformationally constrained amino acids as probes of glutamate receptors and transporters. Kozikowski A.P. Drug design for neuroscience. 1993;231-259 Raven, New York.
5. Choi D.W. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:1990;171-182.
6. Choi D.W. Glutamate receptors and the induction of excitotoxic neuronal death. Prog. Brain Res. 100:1994;47-51.
7. Clark W.G., Vivonia C.A., Baxter C.F. Accurate freehand injection into a lateral brain ventricle of the conscious mouse. J. Appl. Physiol. 25:1988;319-321.
8. Collingridge G.L., Bliss T.V.P. Memories of NMDA receptors and LTP. Trends Neurosci. 18:1995;54-56.
9. Conn P.J., Patel J. The metabotropic glutamate receptors. 1994;1-277 Humana, Toyota (NJ).
10. Cotman C.W., Kahle J.S., Miller S.E., Ulas J., Bridges R.J. Excitatory amino acid neurotransmission. Bloom F.E., Kupfer D.J. Psychopharmacology: the fourth generation of progress. 1995;75-85 Raven Press, New York.
11. Daw N.W., Stein P.S., Fox K. The role of NMDA receptors in information processing. Annu. Rev. Neurosci. 16:1993;207-222.
12. Debonnel G., Beauchesne L., Montigny C. Domoic acid, the alleged "mussel toxin," might produce its neurotoxic effect through kainate receptor activation: an electrophysiological study in rat dorsal hippocampus. Can. J. Physiol. Pharm. 67:1989;29-33.
13. 3H]glutamate binding to fresh and frozen crude plasma membranes isolated from cerebral cortex of adult rats. Biochem. Mol. Biol. Int. 44:1998;1265-1272.
14. Hollman M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
15. Humphrey J.M., Bridges R.J., Chamberlin A.R. 2,3-pyrrolidine dicarboxylates as neurotransmitter conformer mimics: enantioselective synthesis via chelation-controlled enolate alkylation. J. Org. Chem. 59:1994;2467-2472.
16. Ishida M., Shinozaki H. Acromelic acid is a much more potent excitant than kainic acid or domoic acid in the rat spinal cord. Brain Res. 474:1988;386-389.
17. Kanai Y., Smith C.P., Hediger M.A. The elusive transporters with a high affinity for glutamate. Trends Neurosci. 16:1993;365-370.
18. 2+ concentrations induced by (2S,3R,4S)-2- (carboxycyclopropyl)glycine, a new potent NMDA agonist, in cultured rat hippocampal neurons. Brain Res. 567:1991;342.
19. Lanthorn T.H., Hood W.F., Watson G.B., Compton R.P., Rader R.K., Gaoni Y.et al. Cis-2,4-Methanoglutamate is a potent and selective N-methyl-D- aspartate receptor agonist. Eur. J. Pharmacol. 182:1990;397-404.
20. Madsen U., Bang-Andersen B., Brehm L., Christensen I.T., Ebert B., Kristoffersen I.T.S.et al. Synthesis and pharmacology of highly selective carboxy and phosphono isoxazole amino acid AMPA receptor antagonists. J. Med. Chem. 39:1996;1682-1691.
21. Meldrum B.S. Excitotoxicity and selective neuronal loss in epilepsy. Brain Pathol. 3:1993;405-412.
22. Nakanishi S. Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron. 13:1994;1031-1037.
23. Nicolletti F., Bruno V., Capani A., Casabona G., Knöpfel T. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci. 19:1996;267-271.
24. Ortwine D.F., Malone T.C., Bigge C.F., Drummond J.T., Humblet C., Johnson G.et al. Generation of N-methyl-D-aspartate agonist and competitive antagonist pharmacophore models. Design and synthesis of phosphonoalkyl- substituted tetrahydroisoquinolines as novel antagonists. J. Med. Chem. 35:1992;1345-1370.
25. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroenceph. Clin. Neurophysiol. 32:1972;281-294.
26. 3H] glutamate binding sites in rat cerebellum. Biochem. Mol. Biol. Int. 30:1993;861-866.
27. Rothman S.M., Olney J.W. Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci. 18:1995;57-58.
28. Schoepp D.D., Smith C.L., Lodge D., Millar J.D., Leander J.D., Sacaan A.I.et al. D,L-(tetrazol-5-yl)glycine: a novel and highly potent NMDA receptor agonist. Eur. J. Pharmacol. 203:1991;237-243.
29. Schoepp D.D., Lunn W.H.W., Salhoff C.R., McDonald J.W. The NMDA receptor agonist D,L-(tetrazol-5-yl)glycine is a highly potent excitotoxin. Eur. J. Pharmacol. 270:1994;67-72.
30. Shinozaki H., Ishida M., Shimamoto K., Ohfune Y. A conformationally restricted analogue of L-glutamate, the (2S,3R,4S) isomer of L-α-(carboxycyclopropyl)glycine, activates the NMDA-type receptor more markedly than NMDA in the isolated rat spinal cord. Brain Res. 480:1989;355-359.
31. Szatkowski M., Attwell D. Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci. 17:1994;359-365.
32. Watkins J.C., Krogsgaard-Larsen P., Honore T. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol. Sci. 11:1990;25-33.
33. Willis C.L., Humphrey J.M., Koch H.P., Blakely T., Ralston L., Baker C.A.et al. L-Trans-2,3-pyrrolidine dicarboxylate: characterization of a novel excitotoxin. Neuropharmacology. 35:1996;531-539.
34. Willis C.L., Dauenhauer D.L., Humphrey J.M., Chamberlin A.R., Buller A.L., Monaghan D.T.et al. Methylation of the NMDA receptor agonist L-trans-2,3-pyrrolidine-dicarboxylate: enhanced excitotoxic potency and selectivity. Toxicol. Appl. Pharmacol. 144:1997;45-55.